Drugs.com
NOVEMBER 18, 2023
FRIDAY, Nov. 17, 2023 -- Here's another casualty of the pandemic: Gains made against another scourge, HIV. Progress made in fighting HIV/AIDS across all segments of society was eroded during the crisis, according to a report led by researchers at.
Drug Discovery World
NOVEMBER 18, 2023
SLAS 2024 International Conference and Exhibition will take place in Boston, MA, US from 3-7 February 2024.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drugs.com
NOVEMBER 18, 2023
FRIDAY, Nov. 17 (Healthday News) -- The U.S. Food and Drug Administration said Friday it has found early evidence that cinnamon may be the source of high levels of lead in fruit puree pouches that have now sickened 34 children. The agency, in.
Common Sense for Drug Policy Blog
NOVEMBER 18, 2023
Use of Prescription Fentanyl and Illegally Made Fentanyl in the US According to the NSDUH "Among people aged 12 or older in 2022, 0.4 percent (or 991,000 people) misused fentanyl in the past year, including 0.1 percent of adolescents aged 12 to 17, 0.2 percent of young adults aged 18 to 25, and 0.4 percent of adults aged 26 or older (Table A.12B). Corresponding estimated numbers of people who misused fentanyl in the past year were 34,000 adolescents aged 12 to 17, 75,000 young adults aged 18 to
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drugs.com
NOVEMBER 18, 2023
FRIDAY, Nov. 17, 2023 -- A young woman working at a Massachusetts cannabis-processing facility who developed new-onset asthma and later died of a fatal asthma attack is the first such fatality in the burgeoning industry, a new report.
Drug Patent Watch
NOVEMBER 18, 2023
This chart shows the pharmaceutical companies with the most patents in Russian Federation. Patents must be filed in each country (or, in some cases regional patent office) where patent protection… The post Which pharmaceutical companies have the most drug patents in Russian Federation? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Drug & Device Law
NOVEMBER 18, 2023
Several of your Reed Smith bloggers are making plans to be in New York on December 5 – 6 to attend ACI’s annual Drug and Medical Device Litigation conference. We’re looking forward to great content and numerous networking opportunities – and maybe even the chance to catch up with some of our loyal readers. The good people at ACI asked the blog to be a media sponsor this year – and are offering a special registration discount for the conference for the blog’s readers.
Drugs.com
NOVEMBER 18, 2023
FRIDAY, Nov. 17, 2023 -- A wireless, noninvasive device has shown promise in detecting the biomarkers of Alzheimer’s and Parkinson’s diseases. Researchers said the device uses electrical detection to identify proteins associated with.
Drugs.com
NOVEMBER 18, 2023
FRIDAY, Nov. 17, 2023 (Healthday News) -- Scams are nothing new and older folks are known to be vulnerable to them, but a new poll adds another sad fact to the familiar story. Among people aged 50 to 80, those who reported being in fair or poor.
Drugs.com
NOVEMBER 18, 2023
FRIDAY, Nov. 18, 2023 -- Have a hard time looking others in the eye? You aren’t alone, Canadian researchers report. Eye-to-eye contact rarely occurs when two people are talking, they found. “We discovered that participants spent only.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Drugs.com
NOVEMBER 18, 2023
FRIDAY, Nov. 17, 2023 -- Air filters might help keep the air in your home fresh, but a new review finds they don’t appear to reduce your risk of catching an airborne virus. Technologies designed to make indoor spaces safer from infection are.
Drugs.com
NOVEMBER 18, 2023
FRIDAY, Nov. 17, 2023 -- A pregnant woman's mental health might have profound effects on the mind of her unborn child, a new evidence review warns. Children appear to be at higher risk for mental health and behavior issues if their moms were highly.
Drugs.com
NOVEMBER 18, 2023
FRIDAY, Nov. 17, 2023 -- Good news is fun to share, but you get more of a charge from it if you keep it under your hat for a while, a new study says. Keeping good news a secret for a bit before telling someone else appears to make people feel more.
Drugs.com
NOVEMBER 18, 2023
SATURDAY, Nov.18 -- Data showing that the antibiotic doxycycline might prevent a sexually transmitted infection (STI) if taken soon after sex made headlines earlier this year.As surging numbers of cases of syphilis and gonorrhea affect more.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Expert insights. Personalized for you.
111 
Let's personalize your content